Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven, a New Haven‑based biopharma, leads a phase III neuroscience and oncology pipeline—troriluzole for neuropsychiatric disorders, BHV‑7000 for epilepsy/depression—backed by Bristol Myers Squibb, Merus, and academic partners.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 256
- HQ: New Haven
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.